BIOSENSE WEBSTER INC NAVI-STAR¿ THERMO-COOL¿ ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
|
Back to Search Results |
|
Model Number NI75TCJH |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Tamponade (2226)
|
Event Date 08/02/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a 73-year-old female patient (59kg) underwent an atrial fibrillation (afib) ablation procedure with a navi-star¿ thermo-cool¿ electrophysiology catheter.The patient suffered a cardiac tamponade that required a pericardiocentesis.There was a steam pop.It was reported that a steam pop occurred in the left atrial appendage during ablation.They were ablating at 45 watts when the steam pop occurred.The steam pop occurred on the first or second ablation.There was no visible char on the catheter.The flow rate of the catheter was appropriate and the catheter was flushed prior to ablation.The temperature readings displayed on the carto 3 system on and off ablation were normal.Additional information was received.The patient ended up with cardiac tamponade and a pericardiocentesis was done.There were 200 ccs of fluid was removed and the patient was stable.The patient stayed overnight with the drain in place.The drain was removed earlier today and the patient did not require any surgical repair.The physician¿s opinion on the cause of this adverse event was a bwi product malfunction.The patient outcome of the adverse event was fully recovered (no residual effects).The patient required extended hospitalization because of the adverse event, intensive care unit (icu) stay for observation until drain removed.A transseptal puncture was performed with a baylis nrg transseptal needle; standard curve c0; nrg-e-hf-71-c0.The irrigated catheter flow setting was15ml.The correct catheter settings were selected on the generator and the pump was switching from low to high flow during ablation.No errors on biosense webster, inc.Equipment.
|
|
Manufacturer Narrative
|
The device evaluation was completed on 31-aug-2022.It was reported that a 73-year-old female patient (59kg) underwent an atrial fibrillation (afib) ablation procedure with a navi-star¿ thermo-cool¿ electrophysiology catheter.The patient suffered a cardiac tamponade that required a pericardiocentesis.There was a steam pop.The product was returned to biosense webster for evaluation.A visual inspection and an evaluation of all features of the device were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.Per the event, several tests were performed.The magnetic, and temperature features were tested, and no issues were observed.In addition, the product was deflecting and irrigating correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The ifu (instruction for use) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.As part of biosensor webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
The bwi product analysis lab received the device for evaluation on 25-aug-2022.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|
|